# Visgo Therapeutics, Inc. — Form D

Visgo Therapeutics, Inc. of BURLINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-03-09. The offering totals $1.1M, of which $725K was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2015-03-09
- Form: D
- Accession: 0001635772-15-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.1M
- Amount sold: $725K
- Remaining: $375K
- Investors: 7
- Date of first sale: 2015-02-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-235448

## Issuer

- Name: Visgo Therapeutics, Inc.
- CIK: 0001635772
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 67 SOUTH BEDFORD STREET, BURLINGTON, MA, 01803
- Phone: 617-645-7571

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Jeanne Bertonis | Director | Burlington, MA |
| Pamela Hay | Director | Burlington, MA |
| Jeanne Bertonis | Executive Officer | Burlington, MA |
| Pamela Hay | Executive Officer | Burlington, MA |

## More

- [CIK 1635772 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1635772&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001635772-15-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.